VistaGen Therapeutics Inc...

NASDAQ: VTGN · Real-Time Price · USD
3.31
0.35 (12.01%)
At close: Aug 15, 2025, 3:59 PM
3.32
0.27%
After-hours: Aug 15, 2025, 07:58 PM EDT

VistaGen Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net Income
-15.1M -13.63M -14.09M -12.96M -10.73M -9.52M -6.35M -6.59M -6.9M -12.23M -9.76M -17.48M -19.78M -16.69M -10.54M -12.79M -7.74M -6.21M -5.3M -3.3M -3.13M
Depreciation & Amortization
169K 166K 161K 157K 151K 146.5K 143.2K 140.3K 340K 153.6K 132.2K 132.6K 158.4K 133.4K 316K 227.2K 34.5K 40.3K 26.4K 25.5K 25.4K
Stock-Based Compensation
916K 963K 1.08M 1.11M 1.16M 522.5K 506.7K 583.7K 569.1K 601.5K 746.3K 1.03M 956.9K 1.4M 723.8K 764.5K 590.4K 490.2K 730.4K 410.9K 674.6K
Other Working Capital
-2.29M -665K 692K -257K -973K -266.9K 895.8K 124.4K -482.3K -120.4K 334.3K 2.03M 714.9K -435.5K -2.72M 527.9K -2.06B 439.1K -446.7K 3.87M 434.02M
Other Non-Cash Items
-122K -128K -102K -140K -19K 1.21B 524.4K -1.05M -1.21B 3.87M 2.55M 3.35M 927.8K 2.73M 174.7K -174.8K 232.1K 490.2K -364.8K 3.8M -434.4K
Deferred Income Tax
n/a n/a n/a n/a n/a -1.21B -524.4K 1.05M 1.21B -332K -2.47M -3.35M -956.9K n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-4.71M 2.57M 2.67M 946K -1.43M 1.65M 1.16M -325.9K -1.69M 456.3K -1.13M -21.9K 2.72M -435.5K -2.72M 527.9K 714.6K 398.5K -446.7K 3.87M -379.9K
Operating Cash Flow
-18.85M -10.06M -10.28M -10.89M -10.87M -7.2M -4.54M -6.19M -7.89M -7.47M -9.93M -16.34M -15.97M -15.59M -12.05M -11.45M -6.17M -5.28M -4.99M 1M -2.81M
Capital Expenditures
n/a -88K n/a 42K -42K -28.7K -32.3K n/a n/a 212K -12.5K -24.4K -175.1K -100 100.00 -50.5K -149.9K -25.5K -151.1K -98.8K n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a -528.3K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-8.72M -3.92M -2.42M -13.22M -5.42M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
8M 4.53M 2M 5.5M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -103K n/a n/a n/a n/a n/a -212K n/a n/a -175.1M -200.4M n/a n/a -149.9M -275.3M n/a -98.8K n/a
Investing Cash Flow
-788K 527K -422K -7.79M -5.47M -28.7K -32.3K n/a n/a -528.3K -12.5K -24.4K -175.1K -100 100.00 -50.5K -149.9K -25.5K -151.1K -98.8K n/a
Debt Repayment
930K n/a n/a n/a n/a 1K -500 -784.6K -200.9K n/a -311.1K -308.2K -102.2K -200 -1K -900 -900 -900 163.3K -115K 173.7K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a -84.3K n/a -30.2K -59.4K n/a n/a n/a n/a -336.02M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -583.3M n/a n/a -361.8M -1.05B n/a n/a -335.8M
Other Financial Acitivies
n/a n/a 113K 88K n/a n/a -208K 3.7K n/a -398.2K 7K 4.5K 51.6K n/a 2.02M 3.34M 362.75M 1.05B 93.91M 114K 338.62M
Financial Cash Flow
1.49M 1.95M 1.17M n/a 88K -167.8K 93.52M 34.18M 875.6K -398.7K -304.1K -334K -5.5K 23.7K 2.12M 7.35M 991.4K 4.08M 94.07M 12.95M 3M
Net Cash Flow
-18.15M -7.58M -9.53M -18.67M -16.25M -7.39M 88.95M 27.99M -7.02M -8.4M -10.25M -16.7M -16.15M -15.56M -9.93M -4.15M -5.33M -1.22M 88.93M 13.85M 190.8K
Free Cash Flow
-18.85M -10.15M -10.28M -10.84M -10.91M -7.23M -4.57M -6.19M -7.89M -7.26M -9.95M -16.37M -16.14M -15.59M -12.05M -11.5M -6.32M -5.31M -5.14M 904.9K -2.81M